Ensuring accuracy in blood cancer molecular testing
Using genomic biomarkers enables diagnosis, prognosis, and follow-up of patients suffering from cancer. QIAGEN’s
ipsogen portfolio provides a wide range of CE-IVD marked oncohematology diagnostic assays for determining an individual’s biomarker status.
ipsogen kits provide:
- Sensitive qualitative and quantitative assays
- Standardized assays for reproducible results
- Accurate EAC technology for gene transcripts
- Quality control ISO 13485 certification
- Ease of use with the Rotor-Gene Q instrument